Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first1,741 to 1,760 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| RAD21 RAD21 cohesin complex component | 5885 HGNC:9811 | 1 | 35 | 0 | 0 | 2,912 | 3,897 |
| IGF2BP1 insulin like growth factor 2 mRNA binding protein 1 | 10642 HGNC:28866 | 1 | 61 | 0 | 0 | 1,445 | 3,895 |
| XPO5 exportin 5 | 57510 HGNC:17675 | 1 | 29 | 0 | 0 | 2,103 | 3,895 |
| OTC ornithine transcarbamylase | 5009 HGNC:8512 | 1 | 121 | 0 | 0 | 1,195 | 3,886 |
| AQP2 aquaporin 2 | 359 HGNC:634 | 1 | 35 | 0 | 0 | 1,397 | 3,878 |
| DHX58 DExH-box helicase 58 | 79132 HGNC:29517 | 1 | 39 | 0 | 0 | 2,328 | 3,877 |
| SYT1 synaptotagmin 1 | 6857 HGNC:11509 | 1 | 67 | 0 | 0 | 2,238 | 3,871 |
| CEACAM5 CEA cell adhesion molecule 5 | 1048 HGNC:1817 | 1 | 283 | 9 | 16 | 1,309 | 3,868 |
| SLPI secretory leukocyte peptidase inhibitor | 6590 HGNC:11092 | 1 | 166 | 0 | 0 | 2,152 | 3,867 |
| CD177 CD177 molecule | 57126 HGNC:30072 | 1 | 8 | 0 | 0 | 2,218 | 3,864 |
| MIR29C microRNA 29c | 407026 HGNC:31621 | 0 | 0 | 0 | 0 | 1,249 | 3,863 |
| IGKV2D-29 immunoglobulin kappa variable 2D-29 | 28882 HGNC:5800 | 1 | 6 | 0 | 0 | 1,968 | 3,857 |
| MSR1 macrophage scavenger receptor 1 | 4481 HGNC:7376 | 1 | 64 | 0 | 0 | 2,460 | 3,855 |
| PCK1 phosphoenolpyruvate carboxykinase 1 | 5105 HGNC:8724 | 1 | 28 | 0 | 0 | 1,671 | 3,855 |
| GP6 glycoprotein VI platelet | 51206 HGNC:14388 | 1 | 25 | 1 | 5 | 1,402 | 3,850 |
| IFNAR2 interferon alpha and beta receptor subunit 2 | 3455 HGNC:5433 | 1 | 83 | 11 | 1,349 | 2,761 | 3,850 |
| KAT5 lysine acetyltransferase 5 | 10524 HGNC:5275 | 1 | 24 | 0 | 0 | 2,858 | 3,850 |
| ALDH7A1 aldehyde dehydrogenase 7 family member A1 | 501 HGNC:877 | 1 | 26 | 0 | 0 | 2,306 | 3,847 |
| NLRC4 NLR family CARD domain containing 4 | 58484 HGNC:16412 | 1 | 43 | 0 | 0 | 2,100 | 3,844 |
| NRSN1 neurensin 1 | 140767 HGNC:17881 | 1 | 17 | 0 | 0 | 3,368 | 3,844 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=88
{
"data": {
"total": 193990,
"results": [
{
"id": "5885",
"title": "RAD21: RAD21 cohesin complex component",
"summary": "NCBI Gene 5885. 1 protein, 35 patents, 0 drugs, 0 trials, 2,912 NIH grants and 3,897 papers.",
"record": "/library/genes/5885",
"gene_id": 5885,
"symbol": "RAD21",
"name": "RAD21 cohesin complex component",
"hgnc_id": "HGNC:9811",
"counts": {
"proteins": 1,
"patents": 35,
"drugs": 0,
"trials": 0,
"grants": 2912,
"papers": 3897
}
},
{
"id": "10642",
"title": "IGF2BP1: insulin like growth factor 2 mRNA binding protein 1",
"summary": "NCBI Gene 10642. 1 protein, 61 patents, 0 drugs, 0 trials, 1,445 NIH grants and 3,895 papers.",
"record": "/library/genes/10642",
"gene_id": 10642,
"symbol": "IGF2BP1",
"name": "insulin like growth factor 2 mRNA binding protein 1",
"hgnc_id": "HGNC:28866",
"counts": {
"proteins": 1,
"patents": 61,
"drugs": 0,
"trials": 0,
"grants": 1445,
"papers": 3895
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=89",
"request_id": "IzPGi13W9_DkUNgG"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant